Composition for determining solution acidity and alkalinity based on fluorescence signal and its application
By combining a composition of sodium fluorescein and rhodamine 6G lactam ethylenediamine with droplet microfluidic technology, the limitations of pH detection for small-volume samples have been overcome, enabling rapid, real-time, and accurate pH measurement, suitable for large-volume sample detection.
Patent Information
- Application Number
- CN202611230868.X
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2026-08-13
- Publication Date
- 2026-11-17
AI Technical Summary
Existing technologies are susceptible to factors such as ionic strength, temperature and mechanical damage in pH detection of small volume samples, making it difficult to achieve high-throughput and accurate pH measurement, especially in the detection of large batches of samples.
A composition of sodium fluorescein and rhodamine 6G lactam ethylenediamine was developed to achieve rapid real-time pH detection by responding to pH changes with fluorescence signals and combining it with droplet microfluidics technology.
It enables rapid, real-time, and accurate detection of pH values, with a dynamic detection range covering both acidic and alkaline conditions, improving sample detection efficiency and making it suitable for various aqueous solutions requiring pH value detection.
Smart Images

Figure FT_1 
Figure FT_2 
Figure FT_3
Abstract
Description
Technical Field
[0001] This invention relates to the field of chemical analysis, and more particularly to a composition for determining the acidity and alkalinity of a solution based on fluorescence signals and its application. Background Technology
[0002] pH, as a key parameter characterizing the acidity or alkalinity of a solution, plays a crucial role in numerous aspects, including chemical reaction rates, chemical equilibrium, enzyme activity, in vivo environmental homeostasis, industrial production processes, environmental health, and product safety. Precise pH measurement enables processes to be optimized, quality control to mitigate risks, and facilitate scientific research. Droplet microfluidics technology is rapidly transitioning from laboratory research to practical applications. With its significant advantages such as high throughput, low cost, precise control, and multifunctional integration, it has become a core technological support platform for fields such as single-cell analysis, drug screening, synthetic biology, and microchemical production.
[0003] In existing technologies, traditional pH measurement methods require calibration and are susceptible to factors such as ionic strength, temperature, and mechanical damage, posing significant limitations for detecting small-volume samples. Fluorescence methods, with their high sensitivity, real-time response, ease of operation, and low cost, effectively overcome the shortcomings of traditional methods. When measuring the pH of hundreds of thousands or even billions of samples, high-throughput technologies are essential to achieve the goal of measuring thousands to millions of samples in a single batch. Therefore, developing a reagent kit that can convert pH changes into detectable optical signals and combining it with microfluidic technology is of paramount importance, and will have a profound impact on fields such as biomedicine, environmental monitoring, and industrial process control. Summary of the Invention
[0004] This application provides a composition for determining the acidity or alkalinity of a solution. The composition can characterize changes in acidity or alkalinity through fluorescence, and can respond rapidly and in real time to pH changes, accurately testing the pH value of the solution.
[0005] Item 1. A composition for determining the acidity or alkalinity of a solution, comprising sodium fluorescein and rhodamine 6G lactam ethylenediamine, wherein the mass ratio of sodium fluorescein to rhodamine 6G lactam ethylenediamine is (0.001-0.05):1, or the molar ratio of sodium fluorescein to rhodamine 6G lactam ethylenediamine is (0.001-0.1):1.
[0006] Item 2. The composition according to Item 1, wherein the mass ratio of sodium fluorescein to rhodamine 6G lactam ethylenediamine is (0.003-0.04):1, or the molar ratio of sodium fluorescein to rhodamine 6G lactam ethylenediamine is (0.005-0.05):1.
[0007] Item 3. The composition according to Item 1, wherein, in the use state, the composition is prepared as a solution, wherein the concentration of the sodium fluorescein solution is 0.01 mM-1 mM, or the concentration of the rhodamine 6G lactam ethylenediamine solution is 1 mM-10 mM.
[0008] Item 4. The composition according to Item 1, further comprising other substances selected from one or more of cyclodextrin, cucurbitacin, BSA, chitosan, ovalbumin and gelatin.
[0009] Item 5. The composition according to Item 4, wherein, in the use state, the composition is prepared as a solution, and the concentration of the solution of the other substances is 20-200 g / L.
[0010] Item 6. The composition according to Item 4, wherein, in the use state, the composition is prepared as a solution, and the volume ratio of the solution of the other substances to the sodium fluorescein solution and the rhodamine 6G lactam ethylenediamine solution is (1-5):1.
[0011] Use of the composition according to any one of items 7 and 1-6 in determining the acidity or alkalinity of a solution, wherein the pH value measured by the composition is in the range of 3-8, preferably 3.6-7.8.
[0012] Use of the composition of any one of items 8 and 1-6 in droplet microfluidics.
[0013] Item 9. A kit for determining the acidity or alkalinity of a solution, comprising the composition described in any one of items 1-6, preferably including a solvent.
[0014] Item 10. A method for detecting pH value using the composition described in any one of items 1-6 via droplet microfluidics, comprising the following steps: Mix the composition with the sample to be tested and incubate for 0.5-2 hours; The incubated mixture was processed into droplets using a high-throughput picoliter droplet single-cell sorting system. pH value is determined by observing fluorescence signals.
[0015] Beneficial effects This invention, based on the phenomenon of pH changes caused by bacterial metabolites, develops a composition capable of rapidly and in real-time responding to pH changes to determine the pH value of a solution. The composition described in this application has a dynamic detection range covering both acidic and alkaline conditions and exhibits high sensitivity; even a pH change of only 0.2 in the sample can result in a significant change in the fluorescence signal. This composition can be combined with droplet microfluidic technology to further improve the detection efficiency of sample pH values, showing broad application prospects in obtaining bacterial strains that cause pH changes. Furthermore, in addition to the metabolic culture of bacterial strains, the composition described in this application can be applied to any aqueous solution requiring pH change detection, such as the detection of organic acids (lactic acid, acetic acid, citric acid, succinic acid, etc.) and other substances (such as nitrogenase and its substrates, deaminase and its substrates, etc.). Attached Figure Description
[0016] Figure 1 The fluorescence intensity was measured after mixing and incubating samples with different pH values with different volume ratios of sodium fluorescein solution and rhodamine 6G lactam ethylenediamine solution in Example 1. The volume ratios of sodium fluorescein solution and rhodamine 6G lactam ethylenediamine solution were A-5:5, B-6:4, C-7:3, D-8:2, and E-9:1.
[0017] Figure 2 The fluorescence intensity was measured after mixing and incubating compositions containing sodium fluorescein solutions of different concentrations with samples of different pH values. The concentrations of the sodium fluorescein solutions were A - 0.05 mM, B - 0.1 mM, and C - 0.5 mM.
[0018] Figure 3 The fluorescence intensity was measured after mixing and incubating compositions containing different concentrations of 6G ethylenediamine lactam solution with samples of different pH values. The concentrations of the 6G ethylenediamine lactam solution were A-10mM, B-1mM, and C-0.1mM.
[0019] Figure 4 This refers to the dynamic detection range of pH value for the composition described in this invention.
[0020] Figure 5 The images are microscopic images of droplets generated by a high-throughput picoliter droplet single-cell sorting system after the composition of the present invention is mixed and incubated with samples with different pH values. A-pH7 droplets (pH=7) and B-pH4 droplets (pH=4).
[0021] Figure 6The image shows a microscopic examination of the droplets generated by a high-throughput picoliter single-cell sorting system after the composition of the present invention is mixed and incubated with a sample having the same pH value. The other components in the composition are different, namely gelatin, cucurbitacin, ovalbumin, BSA, chitosan, and cyclodextrin.
[0022] Figure 7 The image shows a microscopic examination of droplets generated by a high-throughput picoliter droplet single-cell sorting system after the composition of the present invention is mixed and incubated with samples having the same pH value, wherein the concentration of BSA in the composition is different.
[0023] Figure 8 Microscopic images of droplets generated using a high-throughput picoliter droplet single-cell sorting system were obtained for the compositions described in Table 1. Droplets with lower fluorescence signals were defined as negative droplets, and droplets with higher fluorescence signals were defined as positive droplets. In the figures, A represents negative droplets (pH=4.6), and B represents positive droplets (pH=4).
[0024] Figure 9 The real-time and sorting signal graphs of DREM cell fluorescence signals are shown when the compositions in Table 1 are detected using a high-throughput picoliter droplet single-cell sorting system. Droplets with lower fluorescence signals are defined as negative droplets, and droplets with higher fluorescence signals are defined as positive droplets. In the graph, A - positive droplets (pH=4.0), B - negative droplets (pH=4.6), and C - mixed positive and negative droplets (volume ratio of positive to negative droplets is 7:3).
[0025] Figure 10 Microscopic images of droplets generated using a high-throughput picoliter droplet single-cell sorting system were obtained for the compositions described in Table 1. Droplets with lower fluorescence signals were defined as negative droplets, and droplets with higher fluorescence signals were defined as positive droplets. In the figures, A represents negative droplets (pH=7), and B represents positive droplets (pH=8).
[0026] Figure 11 The real-time and sorting signal graphs of DREM cell fluorescence signals are shown when the compositions in Table 1 are detected using a high-throughput picoliter droplet single-cell sorting system. Droplets with lower fluorescence signals are defined as negative droplets, and droplets with higher fluorescence signals are defined as positive droplets. In the graph, A represents positive droplets (pH=7), B represents negative droplets (pH=8), and C represents mixed positive and negative droplets (the volume ratio of negative to positive droplets is 7:3).
[0027] Figure 12The images show real-time fluorescence and sorting signals of DREM cells when detected using a high-throughput picometer droplet single-cell sorting system. In this image, A represents halogenated amine + BSA, and B represents the composition of this application + BSA. Detailed Implementation
[0028] Specific embodiments of this application will now be described in more detail. While specific implementations of this application are shown, it should be understood that this application can be implemented in various forms and should not be limited to the embodiments set forth herein. Rather, these embodiments are provided to enable a more thorough understanding of this application and to fully convey the scope of this application to those skilled in the art.
[0029] In this application, the term "volume%" means the volume percentage of the modified substance in the composition. For example, "the volume of the sodium fluorescein solution is 10%" means that the sodium fluorescein solution accounts for 10% of the total volume of the solution.
[0030] This application provides a composition for determining the acidity or alkalinity of a solution, comprising sodium fluorescein and rhodamine 6G lactam ethylenediamine, wherein the mass ratio of sodium fluorescein to rhodamine 6G lactam ethylenediamine is (0.001-0.05):1, or the molar ratio of sodium fluorescein to rhodamine 6G lactam ethylenediamine is (0.005-0.05):1.
[0031] In some implementations, the mass ratio of sodium fluorescein to rhodamine 6G lactam ethylenediamine is (0.001-0.05):1, specifically 0.001:1, 0.002:1, 0.003:1, 0.004:1, 0.005:1, 0.006:1, 0.007:1, 0.008:1, 0.009:1, 0.010:1, 0.011:1, 0.012:1, 0.013:1, 0.014:1, 0.015:1, 0.016:1, 0.017:1, 0.018:1, 0.019:1, 0.020:1, 0.021:1, 0.022:1, etc. 1. 0.023:1, 0.024:1, 0.025:1, 0.026:1, 0.027:1, 0.028:1, 0.029:1, 0.030:1, 0.031:1, 0.032:1, 0.033:1, 0.034:1, 0.035:1, 0.036:1, 0.037:1, 0.038:1, 0.039:1, 0.040:1, 0.041:1, 0.042:1, 0.043:1, 0.044:1, 0.045:1, 0.046:1, 0.047:1, 0.048:1, 0.049:1 or 0.05:1.
[0032] In some embodiments, the mass ratio of sodium fluorescein to rhodamine 6G lactam ethylenediamine is (0.003-0.04):1.
[0033] In some implementations, the mass ratio of sodium fluorescein to rhodamine 6G lactam ethylenediamine is 0.0039:1, 0.0059:1, 0.0092:1, 0.016:1, or 0.035:1.
[0034] In some implementations, the mass ratio of sodium fluorescein to rhodamine 6G lactam ethylenediamine is 0.016:1.
[0035] In some implementations, the molar ratio of sodium fluorescein to rhodamine 6G lactam ethylenediamine is (0.005-0.05):1, specifically 0.0050:1, 0.0075:1, 0.0100:1, 0.0125:1, 0.0150:1, 0.0175:1, 0.0200:1, 0.0225:1, 0.0250:1, 0.0275:1, 0.0300:1, 0.0325:1, 0.0350:1, 0.0375:1, 0.0400:1, 0.0425:1, 0.0450:1, or 0.05:1.
[0036] In some implementations, the molar ratio of sodium fluorescein to rhodamine 6G lactam ethylenediamine is 0.005:1, 0.0075:1, 0.012:1, 0.02:1, or 0.045:1.
[0037] In some implementations, the molar ratio of sodium fluorescein to rhodamine 6G lactam ethylenediamine is 0.02:1.
[0038] In some embodiments, in the use state, the composition is prepared as a solution, and the solvent used to prepare the solution may be selected from one or more of water, methanol, anhydrous ethanol, propylene glycol, dimethyl sulfoxide, acetonitrile, N,N-dimethylformamide, phosphate buffer, Tris-HCl buffer, HEPES buffer, citrate buffer, acetate buffer, borate buffer, and aqueous NaCl solution.
[0039] In some embodiments, the composition is prepared as a solution in the use state, and the solvent used to prepare the solution is deionized water and / or anhydrous ethanol.
[0040] In some embodiments, the composition is prepared as a solution in the use state, and the solvent used to prepare the solution is deionized water.
[0041] In some embodiments, the composition is prepared as a solution in the use state, wherein the concentration of the sodium fluorescein solution is 0.01 mM-1 mM, specifically 0.01 mM, 0.05 mM, 0.1 mM, 0.15 mM, 0.2 mM, 0.25 mM, 0.3 mM, 0.35 mM, 0.4 mM, 0.45 mM, 0.5 mM, 0.55 mM, 0.6 mM, 0.65 mM, 0.7 mM, 0.75 mM, 0.8 mM, 0.85 mM, 0.9 mM, 0.95 mM, or 1 mM.
[0042] In some embodiments, the composition is prepared as a solution in the use state, wherein the concentration of the sodium fluorescein solution is 0.01 mM-0.5 mM.
[0043] In some embodiments, the composition is prepared as a solution in the use state, wherein the concentration of the sodium fluorescein solution is 0.01 mM-0.1 mM.
[0044] In some embodiments, the composition is prepared as a solution in the use state, wherein the concentration of the sodium fluorescein solution is 0.05 mM.
[0045] In some embodiments, the composition is prepared as a solution in the use state, wherein the concentration of the rhodamine 6G lactam ethylenediamine solution is 1 mM-10 mM, specifically 1 mM, 2 mM, 3 mM, 4 mM, 5 mM, 6 mM, 7 mM, 8 mM, 9 mM, or 10 mM.
[0046] In some embodiments, the composition is formulated as a solution in the use state, wherein the concentration of the Rhodamine 6G lactam ethylenediamine solution is 5 mM-10 mM.
[0047] In some embodiments, the composition is formulated as a solution in the use state, wherein the concentration of the Rhodamine 6G lactam ethylenediamine solution is 10 mM.
[0048] In some embodiments, the composition further includes other substances selected from one or more of cyclodextrin, cucurbitacin, BSA, chitosan, ovalbumin, and gelatin.
[0049] In some embodiments, the composition includes sodium fluorescein, rhodamine 6G lactam ethylenediamine, and cyclodextrin.
[0050] In some embodiments, the cyclodextrin can be hydroxypropyl α-cyclodextrin, hydroxypropyl β-cyclodextrin, hydroxypropyl γ-cyclodextrin, α-cyclodextrin, β-cyclodextrin, or γ-cyclodextrin.
[0051] In some embodiments, the composition includes sodium fluorescein, rhodamine 6G lactam ethylenediamine, and cucurbituril.
[0052] In some embodiments, the composition includes sodium fluorescein, rhodamine 6G lactam ethylenediamine, and BSA.
[0053] In some embodiments, the composition includes sodium fluorescein, rhodamine 6G lactam ethylenediamine, and chitosan.
[0054] In some embodiments, the composition includes sodium fluorescein, rhodamine 6G lactam ethylenediamine, and ovalbumin.
[0055] In some embodiments, the composition includes sodium fluorescein, rhodamine 6G lactam ethylenediamine, and gelatin.
[0056] In some embodiments, the composition is prepared as a solution in the use state, wherein the concentration of the solution of the other substances is 20-200 g / L, specifically 20 g / L, 30 g / L, 40 g / L, 50 g / L, 60 g / L, 70 g / L, 80 g / L, 90 g / L, 100 g / L, 110 g / L, 120 g / L, 130 g / L, 140 g / L, 150 g / L, 160 g / L, 170 g / L, 180 g / L, 190 g / L, or 200 g / L.
[0057] In some embodiments, the composition is prepared as a solution in the use state, wherein the concentration of the solution of the other substances is 40-160 g / L.
[0058] In some embodiments, the composition is prepared as a solution in the use state, wherein the concentration of the solution of the other substances is 80-160 g / L.
[0059] In some embodiments, the composition is prepared as a solution in the use state, wherein the concentration of the solution of the other substances is 80-120 g / L.
[0060] In some embodiments, the composition is prepared as a solution in the use state, wherein the concentration of the solution of the other substances is 80 g / L.
[0061] In some embodiments, the composition is formulated as a solution in the use state, wherein the other substance is BSA.
[0062] In some embodiments, in the use state, the composition is formulated as a solution, wherein the volume ratio of the solution of the other substances to the sodium fluorescein solution and the rhodamine 6G lactam ethylenediamine solution is (1-5):1, specifically, it can be 1:1, 2:1, 3:1, 4:1 or 5:1.
[0063] In some embodiments, in the use state, the composition is formulated as a solution, wherein the volume ratio of the solution of the other substances to the sodium fluorescein solution and the rhodamine 6G lactam ethylenediamine solution is 1:1.
[0064] This application provides the use of the composition described herein in determining the acidity or alkalinity of a solution.
[0065] In some embodiments, in the composition described in this application or in the use of the composition, the pH value measured by the composition is in the range of 3-8.
[0066] In some embodiments, in the composition or use of the composition described in this application, the pH value of the composition is measured to be in the range of 3.6-7.8.
[0067] In some embodiments, when determining the pH, the composition is prepared as a solution with a concentration of 0.05 mM for the sodium fluorescein solution, wherein the volume of the sodium fluorescein solution is 50-99 volumes, specifically 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, and 99 volumes.
[0068] In some preferred embodiments, when determining the pH, the composition is prepared as a solution with a concentration of 0.05 mM for the sodium fluorescein solution and a volume of 80 vol.
[0069] In some embodiments, when determining the pH, the composition is prepared as a solution with a concentration of 10 mM for the rhodamine 6G lactam ethylenediamine solution, wherein the volume of the rhodamine 6G lactam ethylenediamine solution is 1-50 vol%, specifically 1 vol%, 5 vol%, 10 vol%, 15 vol%, 20 vol%, 25 vol%, 30 vol%, 35 vol%, 40 vol%, 45 vol%, or 50 vol%.
[0070] In some embodiments, when determining the pH, the composition is prepared as a solution with a concentration of 10 mM for the rhodamine 6G lactam ethylenediamine solution, wherein the volume of the rhodamine 6G lactam ethylenediamine solution in the composition is 20 mM.
[0071] In some embodiments, when determining the pH, the composition is prepared as a solution with a concentration of 0.05 mM for sodium fluorescein solution and a concentration of 10 mM for rhodamine 6G lactam ethylenediamine solution, wherein the volume ratio of sodium fluorescein solution to rhodamine 6G lactam ethylenediamine solution is (5-9):(1-5), specifically, it can be 5:1, 5:2, 5:3, 5:4, 5:5, 6:1, 6:2, 6:3, 6:4, 6:5, 7:1, 7:2, 7:3, 7:4, 7:5, 8:1, 8:2, 8:3, 8:4, 8:5, 9:1, 9:2, 9:3, 9:4, 9:5.
[0072] In some embodiments, when determining the pH, the composition is prepared as a solution with a concentration of 0.05 mM for sodium fluorescein solution and a concentration of 10 mM for rhodamine 6G lactam ethylenediamine solution, wherein the volume ratio of sodium fluorescein solution to rhodamine 6G lactam ethylenediamine solution is 5:5, 6:4, 7:3, 8:2, or 9:1.
[0073] In some embodiments, when determining the pH, the composition is prepared as a solution with a concentration of 0.05 mM for sodium fluorescein solution and a concentration of 10 mM for rhodamine 6G lactam ethylenediamine solution, wherein the volume ratio of sodium fluorescein solution to rhodamine 6G lactam ethylenediamine solution is 8:2.
[0074] In some embodiments, when determining pH, the composition is prepared as a solution with a concentration of 0.05 mM for sodium fluorescein solution, a concentration of 10 mM for rhodamine 6G lactam ethylenediamine solution, and a concentration of 80 g / L for the other substances solution. The ratio of the volume of the other substances solution to the sum of the volumes of the sodium fluorescein solution and the rhodamine 6G lactam ethylenediamine solution is 1:(0.1-1), specifically, 1:0.1, 1:0.2, 1:0.3, 1:0.4, 1:0.5, 1:0.6, 1:0.7, 1:0.8, 1:0.9, or 1:1.
[0075] In some embodiments, when determining pH, the composition is prepared as a solution with a concentration of 0.05 mM for sodium fluorescein solution, a concentration of 10 mM for rhodamine 6G lactam ethylenediamine solution, and a concentration of 80 g / L for the other substances solution, wherein the ratio of the volume of the other substances solution to the sum of the volumes of the sodium fluorescein solution and the rhodamine 6G lactam ethylenediamine solution is 1:(0.5-1).
[0076] In some embodiments, when determining pH, the composition is prepared as a solution with a concentration of 0.05 mM for sodium fluorescein solution, a concentration of 10 mM for rhodamine 6G lactam ethylenediamine solution, and a concentration of 80 g / L for the other substances solution, wherein the volume ratio of the other substances solution to the sum of the volumes of the sodium fluorescein solution and the rhodamine 6G lactam ethylenediamine solution is 1:1.
[0077] This application provides for the use of the compositions described herein in droplet microfluidics.
[0078] In some embodiments, when the composition described in this application is used in droplet microfluidics, the composition includes sodium fluorescein, rhodamine 6G lactam ethylenediamine, and cyclodextrin.
[0079] In some embodiments, when the composition described in this application is used in droplet microfluidics, the composition includes sodium fluorescein, rhodamine 6G lactam ethylenediamine, and cucurbituril.
[0080] In some embodiments, when the composition described in this application is used in droplet microfluidics, the composition includes sodium fluorescein, rhodamine 6G lactam ethylenediamine, and BSA.
[0081] In some embodiments, when the composition described in this application is used in droplet microfluidics, the composition includes sodium fluorescein, rhodamine 6G lactam ethylenediamine, and chitosan.
[0082] In some embodiments, when the composition described in this application is used in droplet microfluidics, the composition includes sodium fluorescein, rhodamine 6G lactam ethylenediamine, and ovalbumin.
[0083] In some embodiments, when the composition described in this application is used in droplet microfluidics, the composition includes sodium fluorescein, rhodamine 6G lactam ethylenediamine, and gelatin.
[0084] This application provides a kit for determining the acidity or alkalinity of a solution, comprising the composition described in this application.
[0085] In some embodiments, the kit includes the composition according to this application, and also includes a solvent.
[0086] In some embodiments, the kit includes the composition according to this application, and further includes a solvent selected from one or more of water, methanol, anhydrous ethanol, propylene glycol, dimethyl sulfoxide, acetonitrile, N,N-dimethylformamide, phosphate buffer, Tris-HCl buffer, HEPES buffer, citrate buffer, acetate buffer, borate buffer, and aqueous NaCl solution.
[0087] In some embodiments, the kit includes the composition according to this application, and also includes a solvent, said solvent being deionized water and / or anhydrous ethanol.
[0088] This application provides a method for detecting pH values using the composition described herein via droplet microfluidics. In one embodiment, the method includes the following steps: Mix the composition with the sample to be tested and incubate for 0.5-2 hours; The incubated mixture was processed into droplets using a high-throughput picoliter droplet single-cell sorting system. pH value is determined by fluorescence signal intensity.
[0089] In some embodiments, the volume ratio of the composition to the test sample is 1:1.
[0090] This application provides a method for detecting pH values using the composition described herein via droplet microfluidics. In another embodiment, the method includes the following steps: The sample to be tested is generated into droplets using a high-throughput picosecond droplet single-cell sorting system; The composition was mixed with the droplets and incubated for 0.5-2 hours. pH value is determined by fluorescence signal intensity.
[0091] In some implementation schemes, the incubation time is 0.5-2 hours, specifically 0.5-1 hour, 0.5-1.5 hours, or 0.5-2 hours.
[0092] In some implementation schemes, the incubation time is 0.5-1 hour.
[0093] Example The preferred embodiments of this application have been described in detail above; however, this application is not limited thereto. Within the scope of the technical concept of this application, various simple modifications can be made to the technical solution of this application, including combining various technical features in any other suitable manner. These simple modifications and combinations should also be considered as the content disclosed in this application and are all within the protection scope of this application.
[0094] The exemplary embodiments of this application are described below, including various details of the embodiments of this application to aid understanding, and the results demonstrate the technical effects that can generally be achieved by the implementation methods covered by this application.
[0095] In the examples, the solvents in the sodium fluorescein solution and the 6G ethylenediamine lactone solution were both deionized water. The solvent in the cyclodextrin solution was anhydrous ethanol.
[0096] Example 1: Kit assembly and solution composition optimization.
[0097] Test samples: The test samples used in the examples are acetate buffer (containing acetic acid and sodium acetate) with different pH values and phosphate buffer (containing sodium dihydrogen phosphate and disodium hydrogen phosphate) with different pH values. The test samples with pH values of 3.2, 3.4, 3.6, 3.8 and 4.0 are prepared with acetate buffer, and the test samples with pH values of 7.2, 7.4, 7.6, 7.8 and 8.0 are prepared with phosphate buffer.
[0098] Compositions for pH detection: Compositions of sodium fluorescein solution (molar mass 376.27 g / mol, concentration 0.05 mM) and 6g ethylenediamine lactam solution (molar mass 479.60 g / mol, concentration 10 mM) in volume ratios of 5:5, 6:4, 7:3, 8:2, and 9:1, respectively.
[0099] Each of the above compositions was mixed with the test samples (pH values of 3.2, 3.4, 3.6, 3.8, 4.0, 7.2, 7.4, 7.6, 7.8, and 8.0, respectively) at a volume ratio of 1:1 and incubated at room temperature for 0.5–1 h. 100 μL of each composition was then placed in a black-background microplate, and the fluorescence intensity was measured using a Spectra Max M2 microplate reader at Ex / Em = 488 / 525 nm (green fluorescence) and Ex / Em = 532 / 578 nm (orange-yellow fluorescence), respectively. The test results are as follows: Figure 1 As shown, from Figure 1 It can be seen that when the volume ratio of sodium fluorescein solution to 6G ethylenediamine lactam solution is 8:2, the green fluorescence shows the most significant trend of increasing with increasing pH value, while the orange-yellow fluorescence shows the most obvious trend of increasing with decreasing pH value. Therefore, this ratio is the optimal choice.
[0100] Different concentrations of sodium fluorescein solution were mixed with 10 mM 6G lactam ethylenediamine solution at a volume ratio of 8:2. This mixture was then mixed with samples of different pH values (3.2, 3.4, 3.6, 3.8, 4.0, 7.2, 7.4, 7.6, 7.8, and 8.0) at a volume ratio of 1:1. The mixture was incubated at room temperature for 0.5–1 h. 100 μL of each sample was placed in a black-background microplate, and the fluorescence intensity was measured using a Spectra Max M2 microplate reader at Ex / Em = 488 / 525 nm (green fluorescence) and Ex / Em = 532 / 578 nm (orange-yellow fluorescence). The test results are as follows: Figure 2 As shown, from Figure 2 It can be seen that when the concentration of sodium fluorescein is 0.05 mM, the difference in intensity between green fluorescence and orange-yellow fluorescence is not significant, so this concentration is optimal.
[0101] Different concentrations of 6G ethylenediamine lactam solution were mixed with sodium fluorescein solution (0.05 mM) at a volume ratio of 8:2. This mixture was then mixed with samples of different pH values (3.2, 3.4, 3.6, 3.8, 4.0, 7.2, 7.4, 7.6, 7.8, and 8.0) at a volume ratio of 1:1. The mixture was incubated at room temperature for 0.5–1 h. 100 μL of each sample was placed in a black-background microplate, and the fluorescence intensity was measured using a Spectra Max M2 microplate reader at Ex / Em=488 / 525 nm (green fluorescence) and Ex / Em=532 / 578 nm (orange-yellow fluorescence). The test results are as follows: Figure 3 As shown, from Figure 3 It can be seen that when the concentration of the 6G lactam ethylenediamine solution of Luomingdan is 10 mM, the difference in intensity between orange-yellow fluorescence and green fluorescence is not significant, so this concentration is optimal.
[0102] Example 2: Dynamic response range determination.
[0103] The sodium fluorescein solution (0.05 mM) and the 6g ethylenediamine lactam solution (10 mM) were mixed at a ratio of 8:2 (volume ratio). Then, the mixture was mixed with samples of different pH values (pH range 2.2~8.0, gradient 0.2, a total of 30 samples) at a volume ratio of 1:1 and incubated at room temperature for 0.5-1 h. 100 μL of the mixture was placed in a black-background microplate and the fluorescence intensity was measured using a microplate reader (model Spectra Max M2) at Ex / Em=488 / 525nm (green fluorescence) and Ex / Em=532 / 578nm (orange-yellow fluorescence), respectively.
[0104] Test results are as follows Figure 4 As shown, when the sample pH value is in the range of 3.6-7.8, the stronger the alkalinity of the solution, the stronger the green fluorescence signal; conversely, the stronger the acidity of the solution, the stronger the orange-yellow fluorescence signal. The data trends indicate that the composition described in this application has high sensitivity when testing the pH value of the solution. Even a change of only 0.2 in the pH value of the solution can produce a significant change in the fluorescence signal. Therefore, the dynamic detection range of the composition described in this application covers both acidic and alkaline conditions.
[0105] Example 3: Application of droplet microfluidic system.
[0106] The high-throughput picoliter droplet single-cell sorting system (DREM cell) used in this embodiment is DREM cell-MS83.
[0107] Samples with pH 4 (denoted as pH4, hereinafter the same) and pH 7 were mixed with the composition in Example 2 and incubated. Droplets were then generated using a high-throughput picoliter droplet single-cell sorting system (DREM cell) for microscopic observation. Figure 5 As shown, green fluorescence can be clearly observed under a microscope, which is consistent with Example 2. However, no orange-yellow fluorescence can be observed, which is inconsistent with Example 2. After analysis and investigation, it was found that the orange-yellow fluorescence signal is easily extracted by the oil phase, that is, it has better solubility in the oil phase. Additional solution needs to be added to assist in the stabilization of the orange-yellow signal under acidic conditions.
[0108] A fluorescein sodium solution (0.05 mM) and a rhodamine 6g lactam ethylenediamine solution (10 mM) were mixed at an 8:2 volume ratio. Then, solutions of other substances of equal concentration were added and mixed thoroughly. These other substances included gelatin, cucurbitacin, ovalbumin, BSA, chitosan, and cyclodextrin. The volume ratio of these other solutions to the sum of the volumes of the fluorescein sodium solution and the rhodamine 6g lactam ethylenediamine solution was 1:1. This mixture was then mixed with a sample at pH 4 at a 1:1 volume ratio and incubated at room temperature for 0.5–1 h. Droplets were generated using a high-throughput picoliter droplet single-cell sorting system (DREM cell) and observed under a microscope. The results are as follows: Figure 6 As shown, the orange-yellow signal is most stable when the other substance is BSA.
[0109] A solution of 0.05 mM fluorescein sodium and 10 mM rhodamine 6G lactam ethylenediamine solution were mixed at a ratio of 8:2 (volume ratio). Then, different concentrations of BSA solution (40 g / L, 80 g / L, 120 g / L, and 160 g / L) were added and mixed thoroughly. The volume ratio of the BSA solution to the sum of the volumes of the fluorescein sodium solution and the rhodamine 6G lactam ethylenediamine solution was 1:1. This mixture was then mixed with a sample at pH 4 at a 1:1 volume ratio and incubated at room temperature for 0.5–1 h. Droplets were generated using a high-throughput picoliter droplet single-cell sorting system (DREM cell) and observed under a microscope. The results are as follows: Figure 7 As shown, the orange-yellow signal was most stable when the concentration of the BSA solution was 80 g / L. The composition of the kit at this point is shown in Table 1. In addition, similar concentration tests were performed on gelatin, cucurbitacin, ovalbumin, chitosan, and cyclodextrin, with results similar to those for BSA. To conserve resources, only BSA was used as the other substance in subsequent tests.
[0110] Samples at pH 4, pH 4.6, pH 7, and pH 8 were used to generate droplets via a DREM cell. The compositions shown in Table 1 were then injected into the DREM cell and incubated at room temperature for 0.5–1 h. Microscopic examination followed by DREM cell sorting of pH 4 droplets, pH 4.6 droplets, mixed droplets (pH 4:pH 4.6 volume ratio 7:3), pH 7 droplets, pH 8 droplets, and mixed droplets (pH 7:pH 8 volume ratio 7:3), and fluorescence signals were measured. Figure 8 It can be seen that, with the help of the bright field and dark field fields of the microscope, a significant difference in the signal between pH4 droplets and pH4.6 droplets can be clearly observed, which prepares for the measurement of droplet level signals based on DREM cells.
[0111] Furthermore, single droplets at pH 4.6, single droplets at pH 4, and mixtures of the two droplets were introduced into a DREM cell system, and the signal intensity of different components at Ex / Em = 532 / 578 nm (orange-yellow fluorescence) was measured. The detection results are as follows: Figure 9 As shown, the real-time signal plot and droplet scatter plot demonstrate significant signal differences among the three different components. In the droplet histogram, the signal intensity of the pH4 droplet is significantly higher than that of the pH4.6 droplet. The mixed component of the positive and negative droplets shows two significantly different signal peaks, compared with the signals of single droplet components. Figure 10 As shown, the microscopic images clearly show the signal difference between pH7 and pH8 droplets, which allows for signal measurement at the DREM cell level.
[0112] Similarly, single droplets at pH 7, single droplets at pH 8, and mixtures of the two were measured using a DREM cell system, with the Ex / Em signal intensity at 488 / 525 nm (green fluorescence). Figure 11 The droplet histogram shows that the signal intensity of pH7 droplets is significantly lower than that of pH8 droplets. The mixed components of anion and positivity droplets also show that their signals are the superposition of negative and positive droplet signals, corresponding to the signals of individual droplet components.
[0113] The above results all demonstrate that the composition described in this application can be used for high-throughput sample screening via a microfluidic droplet system. Compared with traditional methods, the composition provided in this application does not require repeated calibration, indirectly improving the detection efficiency of pH. The composition, kit, and testing method provided in this application offer a microfluidic screening system for screening target substances and pH-related strains, potentially accelerating the screening of relevant high-yield strains.
[0114] Comparative Example In the prior art CN121695966A, to address the issue of small molecule leakage, the hydrophobic portion of the fluorescent signal molecule halogen is embedded into the cyclodextrin cavity to enhance water solubility. To verify the compatibility of the composition of this application (fluorescein sodium solution and 6G lactam ethylenediamine) with BSA, a combination of halogen and BSA was specifically set up as a comparative example, as follows.
[0115] BSA solution was mixed with halogenated solution and the composition solution in this patent at a volume ratio of 1:1. These two mixtures were then mixed with a sample at pH 4 at a volume ratio of 1:1 and incubated at room temperature for 0.5-1 h. Droplets were generated using a high-throughput picoliter droplet single-cell sorting system (DREM cell) and observed under a microscope. Results are as follows: Figure 12 As shown, the fluorescence signal of the test halogen is unstable, and there are obvious differences in the intensity of the fluorescence signal of the droplets. Figure 12 A), while the composition in this patent does not exhibit this phenomenon ( Figure 12 Therefore, the BSA solution and the composition in this patent provide a more stable signal.
[0116] The technical features of the above embodiments can be combined in any way. For the sake of brevity, not all possible combinations of the technical features in the above embodiments are described. However, as long as there is no contradiction in the combination of these technical features, they should be considered to be within the scope of this specification.
[0117] The embodiments described above are merely illustrative of several implementation methods of this application, and while the descriptions are specific and detailed, they should not be construed as limiting the scope of this application. It should be noted that those skilled in the art can make various modifications and improvements without departing from the concept of this application, and these all fall within the protection scope of this application. Therefore, the protection scope of this patent application should be determined by the appended claims.
Claims
1. A composition for determining the pH of a solution, wherein, It includes sodium fluorescein and rhodamine 6G lactam ethylenediamine, with the mass ratio of sodium fluorescein to rhodamine 6G lactam ethylenediamine being (0.001-0.05):1, or the molar ratio of sodium fluorescein to rhodamine 6G lactam ethylenediamine being (0.001-0.1):
1.
2. The composition of claim 1, wherein, The mass ratio of sodium fluorescein to rhodamine 6G lactam ethylenediamine is (0.003-0.04):1, or the molar ratio of sodium fluorescein to rhodamine 6G lactam ethylenediamine is (0.005-0.05):
1.
3. The composition of claim 1, wherein, In use, the composition is prepared as a solution, with the concentration of sodium fluorescein solution being 0.01 mM-1 mM, or the concentration of rhodamine 6G lactam ethylenediamine solution being 1 mM-10 mM.
4. The composition of claim 1, wherein, It also includes other substances selected from one or more of cyclodextrin, cucurbitacin, BSA, chitosan, ovalbumin, and gelatin.
5. The composition according to claim 4, wherein, In use, the composition is prepared as a solution, wherein the concentration of the solution of the other substances is 20-200 g / L.
6. The composition according to claim 4, wherein, In use, the composition is prepared as a solution in which the volume ratio of the solution of the other substances to the sodium fluorescein solution and the rhodamine 6G lactam ethylenediamine solution is (1-5):
1.
7. Use of the composition according to any one of claims 1-6 in determining the acidity or alkalinity of a solution, wherein, The pH value of the composition is measured in the range of 3-8, preferably 3.6-7.
8.
8. Use of the composition according to any one of claims 1-6 in droplet microfluidics.
9. A kit for determining the acidity or alkalinity of a solution, comprising the composition of any one of claims 1-6, preferably comprising a solvent.
10. A method for detecting pH value using the composition of any one of claims 1-6 via droplet microfluidics, comprising the following steps: Mix the composition with the sample to be tested and incubate for 0.5-2 hours; The incubated mixture was processed into droplets using a high-throughput picoliter droplet single-cell sorting system. pH value is determined by observing fluorescence signals.
Citation Information
Patent Citations
Micro-droplet preparation method for microfluidic system
CN121695966A
